Three new studies came out this week extolling the disease-fighting properties of grapefruit juice, walnuts and wine.
The research was presented Monday at the 100th annual meeting of the American Association for Cancer Research (AACR.)
A study from the University of Chicago Medical Center claims that combining eight ounces of grapefruit juice with the anti-cancer medicine rapamycin could increase drug levels, allowing lower doses of the [exoebsuve] drug to be given.
A second study presented at the conference found that walnut consumption could provide the body with essential Omega-3 fatty acids, antioxidants and phytosterols that reduce the risk of breast cancer. Researcher Dr Elaine Hardman, of Marshall University School of Medicine, said although the study was carried out in mice, the beneficial effect of walnuts was likely to apply to humans too.
The third study found that drinking wine may increase survival among patients suffering from non-Hodgkin's lymphoma. Researchers at Yale found that those who drank wine had a 76% five-year survival compared with 68% for non-wine drinkers. Further research found five-year, disease-free survival was 70% among those who drank wine compared with 65% among non-wine drinkers.
Beer and/or liquor consumption did not show a benefit.
Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research, with a membership including more than 28,000 researchers, health care professionals and cancer survivors in nearly 90 countries.